Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIOGEN INC. Director's Dealing 2011

Jan 4, 2011

30291_dirs_2011-01-04_739616a5-5416-42be-86dd-b6dc223e0aa0.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOGEN IDEC INC. (BIIB)
CIK: 0000875045
Period of Report: 2010-12-31

Reporting Person: YOUNG WILLIAM (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2010-12-31 Common Stock M 15000 $59.25 Acquired 34315 Direct
2010-12-31 Common Stock F 13256 $67.05 Disposed 21059 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2010-12-31 Stock Option (Right to Buy) $59.25 M 15000 Disposed 2011-01-01 Common Stock (15000) Direct